AACR creates an alliance of academic cancer centers
Foti, Willman, Weiner, and Winn tell us what the new group will seek to accomplish

Capitol Hill

NCI braces for funding cuts, shutdown

White House

White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds

Cancer History Project Free In the Archives

New biography shows how Mary Lasker used money and clout to make the National Cancer Act happen

Conversation with The Cancer Letter

After 51 years, Montefiore Einstein Cancer Center earns the Comprehensive designation

In Brief

UMich Rogel receives $11.1M SPORE for radiosensitization research

Michel Sadelain, Carl June receive 2024 Breakthrough Prize in Life Sciences

Jack Cuzick receives SABCS 2023 William L. McGuire Memorial Lecture Award

VCU Massey Cancer Center changes name to VCU Massey Comprehensive Cancer Center

Johns Hopkins and AccessHope partner to expand remote access to cancer expertise for employers

MD Anderson breaks ground on new facility

Drugs & Targets

FDA approves Ojjaara as first and only treatment for myelofibrosis with anemia

FDA grants Merck sBLA priority review for Keytruda + chemoradiotherapy in cervical cancer

CHMP issues positive opinion on Keytruda in NSCLC indication

CHMP issues positive opinion on Adcetris in Hodgkin lymphoma

FDA approves Akeega for BRCA-positive metastatic castration-resistant prostate cancer

FDA approves new and updated indications for Temodar under Project Renewal

In The Clinic

Carolyn Bertozzi focused on bioorthogonal chemistry in 1996 and won the Nobel Prize in 2022
This is how her discovery got to cancer clinical trials

Conversation with The Cancer Letter

Nobel Prize-winning technology may enable delivery of up to 12x the standard doxorubicin dose

Free Trials & Tribulations

Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot

Using ctDNA as an endpoint in your cancer clinical trial? FDA wants to hear from you

Can ctDNA be used as an endpoint for cancer drug development?
Friends collaboration to present initial results July 11

Latest Issue

Read the latest issue

DOWNLOAD THE PDF

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Oct 2023

JKTG Foundation Symposium: Spatial Analytics, Combination Therapies, and Metastasis

View All Events

Conversations with The Cancer Letter

Shelley Earp steps down at UNC Lineberger, ending a 22-year directorship
A search for his replacement begins

Crystal Denlinger named the first woman to lead NCCN

John Laszlo’s dual role: (1) Working to cure childhood leukemia, and (2) Writing the authoritative book on it
His father, Daniel Laszlo, did early work on folate antagonists

Steve Rosen reads his poems—and tells us why he writes

Contributors

Henry S. Friedman, MD

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community

Lisa M. Dahm

David Alberts, founding member of the University of Arizona Cancer Center, dies at 83

Deborah Doroshow, MD, PhD

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

Mark J. Ratain, MD

What’s the right dose of sotorasib? Is it 240 mg qd or 4x that?
The Oct. 5 ODAC will be a nailbiter

Trending Stories

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community
Obstacles cleared for Bertagnolli’s confirmation as NIH director
Senate HELP Committee schedules hearing
How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
After 51 years, Montefiore Einstein Cancer Center earns the Comprehensive designation
Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
David Alberts, founding member of the University of Arizona Cancer Center, dies at 83

Recent Issues

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

AACR creates an alliance of academic cancer centersFoti, Willman, Weiner, and Winn tell us what the new group will seek to accomplish

Shelley Earp steps down at UNC Lineberger, ending a 22-year directorshipA search for his replacement begins

Crystal Denlinger named the first woman to lead NCCN

John Laszlo’s dual role: (1) Working to cure childhood leukemia, and (2) Writing the authoritative book on itHis father, Daniel Laszlo, did early work on folate antagonists

Steve Rosen reads his poems—and tells us why he writes

Login

AACR creates an alliance of academic cancer centers
Foti, Willman, Weiner, and Winn tell us what the new group will seek to accomplish

Shelley Earp steps down at UNC Lineberger, ending a 22-year directorship
A search for his replacement begins

John Laszlo’s dual role: (1) Working to cure childhood leukemia, and (2) Writing the authoritative book on it
His father, Daniel Laszlo, did early work on folate antagonists